Stock Events

Entheon Biomedical 

$0.09
1
+$0+0% Thursday 20:00

Statistics

Day High
0.05
Day Low
0.05
52W High
0.2
52W Low
0
Volume
40
Avg. Volume
800
Mkt Cap
1.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31AugExpected
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.05
-0.03
-0.01
0.01
Expected EPS
N/A
Actual EPS
0.006

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENTBF. It's not an investment recommendation.
Alphabet
72554
GOOGL
Apple
63389
AAPL
Microsoft
59081
MSFT
Amazon
54705
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap511.54M
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for depression, similar to Entheon's focus on psychedelic therapies.
Mind Medicine
MNMD
Mkt Cap493.47M
Mind Medicine works on developing psychedelic-inspired therapies, directly competing with Entheon's approach in mental health treatment.
ATAI Life Sciences N.V.
ATAI
Mkt Cap218.14M
ATAI Life Sciences is a biotech company developing psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Entheon's market.
GH Research
GHRS
Mkt Cap546.3M
GH Research focuses on developing 5-MeO-DMT therapies for depression, a direct competitor in the psychedelic treatment space.
Cybin
CYBN
Mkt Cap194.47M
Revive Therapeutics
RVVTF
Mkt Cap3.99M
Revive Therapeutics explores psilocybin-based therapies, which is a direct competition to Entheon's psychedelic research and development.
Mydecine Innovations
MYCOF
Mkt Cap649,542
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, competing in the same niche as Entheon.
Seelos Therapeutics
SEEL
Mkt Cap2.04M
Seelos Therapeutics works on projects including ketamine-based treatments, which competes with Entheon's psychedelic-based therapeutic approaches.

About

Health Technology
Pharmaceuticals: Major
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Timothy Ko
Employees
2
Country
CA
ISIN
CA29383X2023

Listings

F
DE
1XU.F
US
ENTBF
CN
CA
ENBI.CN